Chronic hand eczema: A prevalent disease in the general population associated with reduced quality of life and poor overall health measures
BackgroundThe impact of hand eczema (HE) on Health‐Related Quality of Life (HRQoL) has only been sparsely studied in a general population setting, and never by use of the disease specific Quality Of Life in Hand eczema Questionnaire (QOLHEQ).ObjectivesTo examine the HRQoL of unselected individuals w...
Gespeichert in:
| Veröffentlicht in: | Contact dermatitis Jg. 89; H. 6; S. 453 - 463 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Malden
Wiley Subscription Services, Inc
01.12.2023
|
| Schlagworte: | |
| ISSN: | 0105-1873, 1600-0536, 1600-0536 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | BackgroundThe impact of hand eczema (HE) on Health‐Related Quality of Life (HRQoL) has only been sparsely studied in a general population setting, and never by use of the disease specific Quality Of Life in Hand eczema Questionnaire (QOLHEQ).ObjectivesTo examine the HRQoL of unselected individuals with HE using the QOLHEQ. Further, to provide prevalence estimates of severe and chronic HE (CHE), and to contrast overall health related outcomes between individuals with and without HE.MethodsIn this nationwide, cross‐sectional study a questionnaire covering questions on HE related outcomes, and overall health was sent to a random sample of 100 000 Danish adults via a secure digital mailbox, linked to their unique civil registration numbers. Data on demographic characteristics were retrieved from the civil registration system. Individuals reporting HE, further answered the QOLHEQ and other disease specific questions.ResultsThe response rate was 42.7% (n = 42 691). Total estimates of lifetime, 1‐year and point prevalences of HE were 24.4%, 13.3% and 5.8%. Of individuals reporting a 1‐year prevalence, 35.1% reported moderate–severe disease and 82.6% CHE. Individuals with HE were more likely to report less good or poor overall health, and sick leave (any reason), compared to those without. In the 2176 (92.5%) with current HE who completed the QOLHEQ, median QOLHEQ scores corresponded to a moderate impairment of the symptoms and treatment and prevention domains and a slight impairment overall and for the emotions and functioning domains. Factors that were strongly associated with moderate to severe HRQoL impairment included severe, chronic and occupational HE as well as female sex.ConclusionsHE is highly prevalent, bears a considerable burden on society and significantly affects the lives of impacted individuals. Our findings indicate a necessity for targeted prevention aimed at high‐risk groups, and support and treatment for those most affected. |
|---|---|
| AbstractList | The impact of hand eczema (HE) on Health-Related Quality of Life (HRQoL) has only been sparsely studied in a general population setting, and never by use of the disease specific Quality Of Life in Hand eczema Questionnaire (QOLHEQ).BACKGROUNDThe impact of hand eczema (HE) on Health-Related Quality of Life (HRQoL) has only been sparsely studied in a general population setting, and never by use of the disease specific Quality Of Life in Hand eczema Questionnaire (QOLHEQ).To examine the HRQoL of unselected individuals with HE using the QOLHEQ. Further, to provide prevalence estimates of severe and chronic HE (CHE), and to contrast overall health related outcomes between individuals with and without HE.OBJECTIVESTo examine the HRQoL of unselected individuals with HE using the QOLHEQ. Further, to provide prevalence estimates of severe and chronic HE (CHE), and to contrast overall health related outcomes between individuals with and without HE.In this nationwide, cross-sectional study a questionnaire covering questions on HE related outcomes, and overall health was sent to a random sample of 100 000 Danish adults via a secure digital mailbox, linked to their unique civil registration numbers. Data on demographic characteristics were retrieved from the civil registration system. Individuals reporting HE, further answered the QOLHEQ and other disease specific questions.METHODSIn this nationwide, cross-sectional study a questionnaire covering questions on HE related outcomes, and overall health was sent to a random sample of 100 000 Danish adults via a secure digital mailbox, linked to their unique civil registration numbers. Data on demographic characteristics were retrieved from the civil registration system. Individuals reporting HE, further answered the QOLHEQ and other disease specific questions.The response rate was 42.7% (n = 42 691). Total estimates of lifetime, 1-year and point prevalences of HE were 24.4%, 13.3% and 5.8%. Of individuals reporting a 1-year prevalence, 35.1% reported moderate-severe disease and 82.6% CHE. Individuals with HE were more likely to report less good or poor overall health, and sick leave (any reason), compared to those without. In the 2176 (92.5%) with current HE who completed the QOLHEQ, median QOLHEQ scores corresponded to a moderate impairment of the symptoms and treatment and prevention domains and a slight impairment overall and for the emotions and functioning domains. Factors that were strongly associated with moderate to severe HRQoL impairment included severe, chronic and occupational HE as well as female sex.RESULTSThe response rate was 42.7% (n = 42 691). Total estimates of lifetime, 1-year and point prevalences of HE were 24.4%, 13.3% and 5.8%. Of individuals reporting a 1-year prevalence, 35.1% reported moderate-severe disease and 82.6% CHE. Individuals with HE were more likely to report less good or poor overall health, and sick leave (any reason), compared to those without. In the 2176 (92.5%) with current HE who completed the QOLHEQ, median QOLHEQ scores corresponded to a moderate impairment of the symptoms and treatment and prevention domains and a slight impairment overall and for the emotions and functioning domains. Factors that were strongly associated with moderate to severe HRQoL impairment included severe, chronic and occupational HE as well as female sex.HE is highly prevalent, bears a considerable burden on society and significantly affects the lives of impacted individuals. Our findings indicate a necessity for targeted prevention aimed at high-risk groups, and support and treatment for those most affected.CONCLUSIONSHE is highly prevalent, bears a considerable burden on society and significantly affects the lives of impacted individuals. Our findings indicate a necessity for targeted prevention aimed at high-risk groups, and support and treatment for those most affected. BackgroundThe impact of hand eczema (HE) on Health‐Related Quality of Life (HRQoL) has only been sparsely studied in a general population setting, and never by use of the disease specific Quality Of Life in Hand eczema Questionnaire (QOLHEQ).ObjectivesTo examine the HRQoL of unselected individuals with HE using the QOLHEQ. Further, to provide prevalence estimates of severe and chronic HE (CHE), and to contrast overall health related outcomes between individuals with and without HE.MethodsIn this nationwide, cross‐sectional study a questionnaire covering questions on HE related outcomes, and overall health was sent to a random sample of 100 000 Danish adults via a secure digital mailbox, linked to their unique civil registration numbers. Data on demographic characteristics were retrieved from the civil registration system. Individuals reporting HE, further answered the QOLHEQ and other disease specific questions.ResultsThe response rate was 42.7% (n = 42 691). Total estimates of lifetime, 1‐year and point prevalences of HE were 24.4%, 13.3% and 5.8%. Of individuals reporting a 1‐year prevalence, 35.1% reported moderate–severe disease and 82.6% CHE. Individuals with HE were more likely to report less good or poor overall health, and sick leave (any reason), compared to those without. In the 2176 (92.5%) with current HE who completed the QOLHEQ, median QOLHEQ scores corresponded to a moderate impairment of the symptoms and treatment and prevention domains and a slight impairment overall and for the emotions and functioning domains. Factors that were strongly associated with moderate to severe HRQoL impairment included severe, chronic and occupational HE as well as female sex.ConclusionsHE is highly prevalent, bears a considerable burden on society and significantly affects the lives of impacted individuals. Our findings indicate a necessity for targeted prevention aimed at high‐risk groups, and support and treatment for those most affected. |
| Author | Dietz, Jojo Biel‐Nielsen Johansen, Jeanne Duus Quaade, Anna Sophie Erichsen, Christina Yndal Alinaghi, Farzad |
| Author_xml | – sequence: 1 givenname: Anna Sophie orcidid: 0000-0002-8966-4545 surname: Quaade fullname: Quaade, Anna Sophie organization: National Allergy Research Centre, Department of Dermatology and Allergy Copenhagen University Hospital Herlev‐Gentofte Hellerup Denmark – sequence: 2 givenname: Farzad orcidid: 0000-0003-1527-4242 surname: Alinaghi fullname: Alinaghi, Farzad organization: National Allergy Research Centre, Department of Dermatology and Allergy Copenhagen University Hospital Herlev‐Gentofte Hellerup Denmark – sequence: 3 givenname: Jojo Biel‐Nielsen orcidid: 0000-0002-3138-4591 surname: Dietz fullname: Dietz, Jojo Biel‐Nielsen organization: National Allergy Research Centre, Department of Dermatology and Allergy Copenhagen University Hospital Herlev‐Gentofte Hellerup Denmark – sequence: 4 givenname: Christina Yndal orcidid: 0000-0002-8167-4968 surname: Erichsen fullname: Erichsen, Christina Yndal organization: National Allergy Research Centre, Department of Dermatology and Allergy Copenhagen University Hospital Herlev‐Gentofte Hellerup Denmark – sequence: 5 givenname: Jeanne Duus orcidid: 0000-0002-3537-8463 surname: Johansen fullname: Johansen, Jeanne Duus organization: National Allergy Research Centre, Department of Dermatology and Allergy Copenhagen University Hospital Herlev‐Gentofte Hellerup Denmark |
| BookMark | eNptkc9u2zAMxoUhA5Z0PewNCPSyHdxKsi0ruxVB_wEBdtnOhirRswpFciS5Q_cKe-kqSU_FdKFI_PiR4LciCx88EvKF0UtW3pUO5pI1De0-kCUTlFa0rcWCLCmjbcVkV38iq5SeKGWi4XJJ_m3GGLzVMCpvAPVf3KnvcA1TxGfl0GcwNqFKCNZDHhF-o8eoHExhmp3KNnhQKQVtVUYDf2weIaKZdUn2s3I2v0AYwNkB4TBhCiFCeD5IOBhRucLviv4cMX0mHwflEp6_xTPy6_bm5-a-2v64e9hcbytd8zZXnBqJUmA3dHwQpmFadILVDReD4aLWreQ1b8R6jcgN63jHhVG6_EqJq8e6PiNfT7pTDPsZU-53Nml0TnkMc-q5bGVDRdvKgl68Q5_CHH3ZrlBSlEOvu7ZQ306UjiGliEM_RbtT8aVntD_Y0hdb-qMthb16x2qbj3fMUVn3n45XlkiSeA |
| CitedBy_id | crossref_primary_10_1111_cod_14691 crossref_primary_10_1007_s40664_025_00584_1 crossref_primary_10_1080_22423982_2024_2412378 crossref_primary_10_1177_21650799231221140 crossref_primary_10_1016_j_jid_2025_04_031 crossref_primary_10_2196_52159 crossref_primary_10_1007_s13555_024_01312_y crossref_primary_10_1093_bjd_ljaf066 crossref_primary_10_1111_cod_14649 crossref_primary_10_1093_bjd_ljaf020 crossref_primary_10_2340_actadv_v105_43771 crossref_primary_10_1111_cod_14426 crossref_primary_10_1111_cod_70015 crossref_primary_10_1111_jdv_19742 crossref_primary_10_1111_cod_14781 crossref_primary_10_1007_s13555_025_01433_y crossref_primary_10_61409_V10240682 crossref_primary_10_2340_actadv_v105_42596 crossref_primary_10_1016_S0140_6736_24_01810_5 crossref_primary_10_1111_cod_14819 crossref_primary_10_1111_cod_14616 crossref_primary_10_1089_derm_2024_0186 crossref_primary_10_1016_j_jaci_2024_12_1091 crossref_primary_10_1111_cod_14457 crossref_primary_10_1111_cod_14732 crossref_primary_10_2340_actadv_v104_39822 crossref_primary_10_1111_cod_14775 |
| Cites_doi | 10.1111/cod.14276 10.1111/j.0105-1873.2003.00159.x 10.1034/j.1600-0536.2001.045002099.x 10.2340/actadv.v101.432 10.1111/cod.13804 10.1111/j.1600-0536.2009.01625.x 10.1093/bjd/ljad110 10.1111/j.1600-0536.1990.tb00076.x 10.1111/j.1365-2133.2007.08431.x 10.2340/00015555-1111 10.1016/j.jdin.2022.02.009 10.1111/1346-8138.14646 10.1111/bjd.12819 10.1016/j.socscimed.2009.05.013 10.1034/j.1600-0536.2002.470203.x 10.1111/j.0022-202X.2004.22604.x 10.1111/j.1365-2133.2004.06270.x 10.1111/cod.14104 10.1111/j.1600-0536.2009.01630.x 10.1111/cod.14035 10.1111/j.1600-0536.2009.01669.x 10.1111/j.1365-2133.2009.09099.x 10.1111/cod.12962 10.1111/bjd.18558 10.1016/j.jid.2017.02.969 10.1111/j.1600-0536.2011.01908.x 10.1016/j.jid.2019.08.450 10.1016/j.jbi.2019.103208 10.2196/jmir.8353 10.1111/j.1365-2133.2009.09378.x 10.2340/0001555577455457 10.1111/j.1365-2133.2008.08907.x 10.1007/s40257-021-00669-6 10.1038/sj.jid.5700750 10.1111/jdv.16061 10.1111/cod.12067 10.1111/cod.14228 10.1111/bjd.14476 10.1111/j.1525-1497.2005.00291.x 10.1111/bjd.14031 |
| ContentType | Journal Article |
| Copyright | 2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd. |
| Copyright_xml | – notice: 2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd. |
| DBID | AAYXX CITATION 7T5 H94 7X8 |
| DOI | 10.1111/cod.14407 |
| DatabaseName | CrossRef Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1600-0536 |
| EndPage | 463 |
| ExternalDocumentID | 10_1111_cod_14407 |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1CY 1OB 1OC 29F 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAKAS AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAYXX AAZKR ABCQN ABCUV ABDBF ABEML ABHFT ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AIACR AIAGR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG CITATION COF CS3 CYRXZ D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LMP LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O8X O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR X7M XG1 YOC YUY ZGI ZXP ZZTAW ~IA ~WT 7T5 H94 7X8 |
| ID | FETCH-LOGICAL-c325t-20d8e86e7f72f6d41c67613426fd263c582324699ee2d172726dacd176992ab33 |
| ISICitedReferencesCount | 27 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001063704400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0105-1873 1600-0536 |
| IngestDate | Thu Jul 10 23:07:03 EDT 2025 Fri Jul 25 10:37:40 EDT 2025 Sat Nov 29 05:45:30 EST 2025 Tue Nov 18 22:14:14 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c325t-20d8e86e7f72f6d41c67613426fd263c582324699ee2d172726dacd176992ab33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-3138-4591 0000-0003-1527-4242 0000-0002-8167-4968 0000-0002-3537-8463 0000-0002-8966-4545 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cod.14407 |
| PQID | 2886440975 |
| PQPubID | 105341 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_2858406558 proquest_journals_2886440975 crossref_primary_10_1111_cod_14407 crossref_citationtrail_10_1111_cod_14407 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-12-00 20231201 |
| PublicationDateYYYYMMDD | 2023-12-01 |
| PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-00 |
| PublicationDecade | 2020 |
| PublicationPlace | Malden |
| PublicationPlace_xml | – name: Malden |
| PublicationTitle | Contact dermatitis |
| PublicationYear | 2023 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | e_1_2_11_10_1 e_1_2_11_32_1 e_1_2_11_31_1 e_1_2_11_30_1 e_1_2_11_36_1 e_1_2_11_14_1 e_1_2_11_13_1 e_1_2_11_35_1 e_1_2_11_12_1 e_1_2_11_34_1 e_1_2_11_11_1 e_1_2_11_33_1 e_1_2_11_7_1 e_1_2_11_29_1 e_1_2_11_6_1 e_1_2_11_28_1 e_1_2_11_5_1 e_1_2_11_27_1 e_1_2_11_4_1 e_1_2_11_26_1 e_1_2_11_3_1 e_1_2_11_2_1 Voorberg AN (e_1_2_11_39_1) 2023 e_1_2_11_21_1 e_1_2_11_44_1 e_1_2_11_20_1 e_1_2_11_45_1 e_1_2_11_25_1 e_1_2_11_40_1 e_1_2_11_24_1 e_1_2_11_41_1 e_1_2_11_9_1 e_1_2_11_23_1 e_1_2_11_42_1 e_1_2_11_8_1 e_1_2_11_22_1 e_1_2_11_43_1 e_1_2_11_18_1 e_1_2_11_17_1 e_1_2_11_16_1 e_1_2_11_15_1 e_1_2_11_37_1 e_1_2_11_38_1 e_1_2_11_19_1 |
| References_xml | – ident: e_1_2_11_6_1 doi: 10.1111/cod.14276 – ident: e_1_2_11_23_1 doi: 10.1111/j.0105-1873.2003.00159.x – ident: e_1_2_11_24_1 doi: 10.1034/j.1600-0536.2001.045002099.x – ident: e_1_2_11_37_1 doi: 10.2340/actadv.v101.432 – ident: e_1_2_11_2_1 doi: 10.1111/cod.13804 – ident: e_1_2_11_21_1 – ident: e_1_2_11_34_1 doi: 10.1111/j.1600-0536.2009.01625.x – ident: e_1_2_11_38_1 doi: 10.1093/bjd/ljad110 – ident: e_1_2_11_13_1 doi: 10.1111/j.1600-0536.1990.tb00076.x – ident: e_1_2_11_12_1 doi: 10.1111/j.1365-2133.2007.08431.x – ident: e_1_2_11_15_1 doi: 10.2340/00015555-1111 – ident: e_1_2_11_8_1 doi: 10.1016/j.jdin.2022.02.009 – ident: e_1_2_11_18_1 doi: 10.1111/1346-8138.14646 – ident: e_1_2_11_16_1 doi: 10.1111/bjd.12819 – ident: e_1_2_11_41_1 doi: 10.1016/j.socscimed.2009.05.013 – ident: e_1_2_11_36_1 doi: 10.1034/j.1600-0536.2002.470203.x – ident: e_1_2_11_9_1 doi: 10.1111/j.0022-202X.2004.22604.x – ident: e_1_2_11_27_1 doi: 10.1111/j.1365-2133.2004.06270.x – ident: e_1_2_11_7_1 doi: 10.1111/cod.14104 – ident: e_1_2_11_5_1 doi: 10.1111/j.1600-0536.2009.01630.x – ident: e_1_2_11_40_1 doi: 10.1111/cod.14035 – ident: e_1_2_11_11_1 doi: 10.1111/j.1600-0536.2009.01669.x – start-page: 1 year: 2023 ident: e_1_2_11_39_1 article-title: Efficacy and safety of dupilumab in patients with severe chronic hand eczema with inadequate response or intolerance to alitretinoin: a randomized, double‐blind, placebo‐controlled phase IIb proof‐of‐concept study publication-title: Br J Dermatol – ident: e_1_2_11_14_1 doi: 10.1111/j.1365-2133.2009.09099.x – ident: e_1_2_11_10_1 doi: 10.1111/cod.12962 – ident: e_1_2_11_45_1 – ident: e_1_2_11_19_1 doi: 10.1111/bjd.18558 – ident: e_1_2_11_20_1 doi: 10.1016/j.jid.2017.02.969 – ident: e_1_2_11_25_1 doi: 10.1111/j.1600-0536.2011.01908.x – ident: e_1_2_11_31_1 doi: 10.1016/j.jid.2019.08.450 – ident: e_1_2_11_22_1 doi: 10.1016/j.jbi.2019.103208 – ident: e_1_2_11_44_1 doi: 10.2196/jmir.8353 – ident: e_1_2_11_35_1 doi: 10.1111/j.1365-2133.2009.09378.x – ident: e_1_2_11_26_1 doi: 10.2340/0001555577455457 – ident: e_1_2_11_28_1 doi: 10.1111/j.1365-2133.2008.08907.x – ident: e_1_2_11_43_1 doi: 10.1007/s40257-021-00669-6 – ident: e_1_2_11_33_1 doi: 10.1038/sj.jid.5700750 – ident: e_1_2_11_3_1 doi: 10.1111/jdv.16061 – ident: e_1_2_11_4_1 doi: 10.1111/cod.12067 – ident: e_1_2_11_17_1 doi: 10.1111/cod.14228 – ident: e_1_2_11_32_1 doi: 10.1111/bjd.14476 – ident: e_1_2_11_42_1 doi: 10.1111/j.1525-1497.2005.00291.x – ident: e_1_2_11_29_1 doi: 10.1111/bjd.14031 – ident: e_1_2_11_30_1 |
| SSID | ssj0016428 |
| Score | 2.5097368 |
| Snippet | BackgroundThe impact of hand eczema (HE) on Health‐Related Quality of Life (HRQoL) has only been sparsely studied in a general population setting, and never by... The impact of hand eczema (HE) on Health-Related Quality of Life (HRQoL) has only been sparsely studied in a general population setting, and never by use of... |
| SourceID | proquest crossref |
| SourceType | Aggregation Database Enrichment Source Index Database |
| StartPage | 453 |
| SubjectTerms | Eczema Health care Medical treatment Prevention Quality of life Questionnaires Risk groups Sick leave |
| Title | Chronic hand eczema: A prevalent disease in the general population associated with reduced quality of life and poor overall health measures |
| URI | https://www.proquest.com/docview/2886440975 https://www.proquest.com/docview/2858406558 |
| Volume | 89 |
| WOSCitedRecordID | wos001063704400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1600-0536 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0016428 issn: 0105-1873 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6aFiEuiKcIlGpBCCFZRsk6fnEr0IhDCa9UCidr17umRqlt3KSq8hf408x4x06KeB64WI6zsuWdz7MzOzPfMPbYhINMeipz9WAo3RGsWa5KfeVGGQBkqIQYyKZryWE4mUSzWfxuq3eprYU5m4dFEZ2fx9V_FTVcA2Fj6ew_iLu7KVyAcxA6HEHscPwrwRPdrdNsiZt0ZU6kLT-vaqT2xtg_RWXaHMfPlnraqbpmXo4kqbXJ6TUyvMIPW4PZROXneWZDD1VZ1g5mgmKU29ZVOid26_F00_ZFIiysyNTGmsl5Z86_X0qi_0U-Z-djWR3nayhiybDtPeyMZb2Sep3186V0XuRm3mVsTHJc6gtQ5Gax6pwFUPXHtNFkuRTghs6nQtNM0p6H8H7IH_mzZt3cMUWq1cj2S3lmrJYPsJzet8wr7TJgOxkR3Dd1-sj3NsyDkdXHv1h5Ulj0MFwerpfXNqVg8jYZHx0eJtOD2fRJ9dXFxmeYIEBdYHpsR4R-DIp559UHGNiFwtBBbPJw6T2IHgvT0bqnXTSqLtoUjaE0vc6ukYfD9y0yb7AtU9xkV95QDsct9o0AyhGg3AL0Od_nHTw5wZPnBQd4coInX8OTr-HJEZ6c4MkJnrzMOMKT4xMQnpzgyS08eQvP2-xofDB9-dqlliBu6gl_AR-6jkwUmDALRRbo0TANQjBIwczMtAi81I_QQwji2Bih0TYXgZYpnMElIZXn3WHbRVmYu4xrFSuNfI6eUqNYhEoOFRizJpXKxDrz-uxpO6dJSnz52LZlnrR-M0x_0kx_nz3qhlaWJOZng3ZbwSSkLk4TEUXgkAzi0O-zh93foOExbCcLUy5xDDgJ4Cn40b3f3-I-u7r-WHbZ9qJemgfscnoGH3S9x3rhLNojdH0HXrbPlg |
| linkProvider | Wiley-Blackwell |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chronic+hand+eczema%3A+A+prevalent+disease+in+the+general+population+associated+with+reduced+quality+of+life+and+poor+overall+health+measures&rft.jtitle=Contact+dermatitis&rft.au=Quaade%2C+Anna+Sophie&rft.au=Alinaghi%2C+Farzad&rft.au=Jojo+Biel%E2%80%90Nielsen+Dietz&rft.au=Erichsen%2C+Christina+Yndal&rft.date=2023-12-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0105-1873&rft.eissn=1600-0536&rft.volume=89&rft.issue=6&rft.spage=453&rft.epage=463&rft_id=info:doi/10.1111%2Fcod.14407&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-1873&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-1873&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-1873&client=summon |